Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 7/20 | 0.43 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 4/20 | 0.42 |
| ▸ | THRB | P10828 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SMO | Q99835 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625733 | 0.95 | MAP3K12 (0.42) | MAP3K12MAPTPIK3CATHRB | |
| SCHEMBL624870 | 0.90 | MAPT (0.42) | MAP3K12MAPTPIK3CATHRB | |
| SCHEMBL626169 | 0.88 | MAP3K12 (0.41) | MAP3K12MAPTPIK3CATHRBGAA | |
| SCHEMBL624967 | 0.86 | PIK3CA (0.55) | MAP3K12PIK3CASMO | |
| SCHEMBL627411 | 0.85 | MAP3K12 (0.47) | MAP3K12MAPTPIK3CA | |
| SCHEMBL625621 | 0.84 | MAP3K12 (0.46) | MAP3K12MAPTPIK3CA | |
| SCHEMBL626106 | 0.84 | THRB (0.49) | MAPTPIK3CATHRBGAA | |
| SCHEMBL625132 | 0.84 | CKS1B (0.42) | MAP3K12MAPTPIK3CATHRBGAA | |
| SCHEMBL627373 | 0.83 | MAP3K12 (0.46) | MAP3K12MAPTPIK3CATHRB | |
| SCHEMBL626464 | 0.83 | MAPT (0.47) | MAP3K12MAPTPIK3CATHRBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |